Jefferies Financial Group lowered shares of SomaLogic (NASDAQ:SLGC – Free Report) from a buy rating to a hold rating in a research note released on Thursday morning, Marketbeat reports. Jefferies Financial Group currently has $2.30 price target on the stock, down from their prior price target of $3.50. Other research analysts have also issued research […]
SomaLogic Inc.’s stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in.
By Dean Seal Shares of SomaLogic jumped while Standard BioTools shares declined after the companies agreed to an all-stock merger. SomaLogic's stock was up.
By Dean Seal SomaLogic and Standard BioTools have agreed to combine in an all-stock merger. The companies said Wednesday that the tie-up would create a.
Canaccord Genuity Group lowered shares of SomaLogic (NASDAQ:SLGC – Free Report) from a buy rating to a hold rating in a research report released on Monday morning, Marketbeat.com reports. Canaccord Genuity Group currently has $2.50 price objective on the stock, down from their prior price objective of $5.00. SomaLogic Stock Performance NASDAQ:SLGC opened at $2.36 […]